Stockscreener 앱 받기
0.591
0.67%
-0.004
시간 외 거래:
.60
0.009
+1.52%
전일 마감가:
$0.595
열려 있는:
$0.609
하루 거래량:
8,136
Relative Volume:
0.01
시가총액:
$5.59M
수익:
$453.80K
순이익/손실:
$-1.03M
주가수익비율:
-5.2394
EPS:
-0.1128
순현금흐름:
-
1주 성능:
-6.19%
1개월 성능:
-33.54%
6개월 성능:
-87.76%
1년 성능:
-87.04%
1일 변동 폭
$0.59
$0.6111
1주일 범위
$0.58
$0.6523
52주 변동 폭
$0.5301
$10.28
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Compare XTLB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
0.591 | 5.63M | 453.80K | -1.03M | 0 | -0.1128 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-05-08 | 개시 | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr 주식(XTLB)의 최신 뉴스
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires - The Globe and Mail
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination - The Globe and Mail
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice - Investing.com
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice By Investing.com - Investing.com South Africa
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement - TipRanks
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling - TipRanks
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum - The Globe and Mail
XTLB Stock Price, Forecast & Analysis | XTL BIOPHARMACEUTICALS-ADR (NASDAQ:XTLB) - ChartMill
XTL Biopharmaceuticals announces CFO transition amid strategic appointments - MSN
XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency - TipRanks
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure - TipRanks
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance - TipRanks
XTL Biopharmaceuticals Calls February 17 Extraordinary Meeting to Expand Share Capital and Approve NeuroNOS-Linked Financing - The Globe and Mail
Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments - Benzinga
XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement - TipRanks
XTL Biopharmaceuticals schedules extraordinary general meeting for February - Investing.com
XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results - The Globe and Mail
XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance - TipRanks
XTL Biopharmaceuticals receives Nasdaq minimum bid price notice - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
XTL Biopharmaceuticals Faces Leadership Changes at Social Proxy Subsidiary - The Globe and Mail
XTL Biopharmaceuticals Announces CFO Transition Amid Strategic Appointments - The Globe and Mail
Total debt per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A2DK34 - TradingView
These stocks that are showing activity before the opening bell on Friday. - Chartmill
Changes in working capital of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:H2K2 - TradingView
XTL Biopharmaceuticals Announces Board Changes Following Resignation - MSN
XTL Biopharmaceuticals: Shifting Gears or Grounded Reality? - StocksToTrade
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD. - Nasdaq
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — NASDAQ:XTLB - TradingView
symbol__ Stock Quote Price and Forecast - CNN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India
Unusual VolumeStock ScreenerNews - Finviz
XTLB Stock Price and Chart — NASDAQ:XTLB - TradingView
XTL Biopharmaceuticals Ltd Share Price ADR Each Repr 100 Shs Spon - Hargreaves Lansdown
XTLB Financial Statements & ChartsX.t.l. Biopharmaceuticals Ltd.Adr MacroTrends - CMLviz
XTLB Pivot Points, Technical Analysis and Moving AveragesX.t.l. Biopharmaceuticals Ltd.Adr Technicals - CMLviz
List of US Companies Releasing Earnings (EPS) Today - FXLeaders
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga
XTLB Stock Price and Chart — TASE:XTLB - TradingView
XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Check out X T L Biopharmaceuticals Ltd's stock price (XTLB) in real time - CNBC
XTLBX.T.L. Biopharmaceuticals Ltd. ADR Stock Price and Quote - Finviz
INGN Stock Price | Inogen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
X T L Biopharmaceuticals Ltd Adr (XTLB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):